دورية أكاديمية
Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy.
العنوان: | Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy. |
---|---|
المؤلفون: | Santana CR; Faculty of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil., de Oliveira MGG; Faculty of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil., Camargo MS; Faculty of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil., Moreira PMB; Municipal Health Department of Vitória da Conquista, Vitória da Conquista, Bahia, Brazil., de Castro PR; Multidisciplinary Institute of Health, Federal University of Bahia, Vitória da Conquista, Brazil., Aguiar EC; Faculty of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil., Mistro S; Faculty of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil. |
المصدر: | The International journal of pharmacy practice [Int J Pharm Pract] 2024 Feb 15; Vol. 32 (1), pp. 46-51. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9204243 Publication Model: Print Cited Medium: Internet ISSN: 2042-7174 (Electronic) Linking ISSN: 09617671 NLM ISO Abbreviation: Int J Pharm Pract Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2021- : [Oxford] : Oxford University Press Original Publication: London, England : Royal Pharmaceutical Society of Great Britain, c1991- |
مواضيع طبية MeSH: | Diabetes Mellitus, Type 2*/diagnosis , Prediabetic State*/diagnosis , Pharmacies*, Humans ; Middle Aged ; Young Adult ; Adult ; Aged ; Aged, 80 and over ; Glycated Hemoglobin ; Point-of-Care Systems ; Cross-Sectional Studies ; Point-of-Care Testing ; Pharmaceutical Preparations |
مستخلص: | Objectives: To evaluate the use of point-of-care testing to detect new cases of diabetes mellitus at a Brazilian public community pharmacy. Methods: This cross-sectional study included individuals without a previous diagnosis of diabetes mellitus who met the criteria for screening according to the Brazilian Diabetes Society, which were identified during their presence at a Brazilian public community pharmacy. The measurements of HbA1c were performed using a Cobas b101 device (Roche Diagnostics) and were categorized according to the following classification established by the Brazilian Society of Diabetes: HbA1c <5.7%, normal; HbA1c between 5.7% and 6.4%, pre-diabetes; and HbA1c >6.4%, new diagnosis of T2DM. Key Findings: One hundred and eight users met the inclusion criteria. The patients' mean age was 54.4 (± 15.4) years old, ranging from 22 to 80 years old. Eighty (74.1%) participants presented with glycated haemoglobin levels over the standard threshold, of which 58 (72.5%) were in the pre-diabetes range (glycated haemoglobin levels between 5.7% and 6.4%), and 22 (27.5%) had glycated haemoglobin levels >6.4%, which corresponds to a new diagnosis of type 2 diabetes mellitus. Conclusions: The use of point-of-care glycated haemoglobin testing allowed community pharmacists at a Brazilian public community pharmacy to identify health system users with glycated haemoglobin alterations that corresponded to the pre-diabetes state or a new diagnosis of type 2 diabetes mellitus. This presented a good opportunity to refer these users to diabetes diagnosis and treatment services. (© The Author(s) 2023. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society.) |
معلومات مُعتمدة: | 255790 Medtronic Foundation; 001 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior |
فهرسة مساهمة: | Keywords: community pharmacy services; pharmaceutical care; point-of-care testing; screening; type 2 diabetes mellitus |
المشرفين على المادة: | 0 (Glycated Hemoglobin) 0 (Pharmaceutical Preparations) |
تواريخ الأحداث: | Date Created: 20231108 Date Completed: 20240219 Latest Revision: 20240219 |
رمز التحديث: | 20240219 |
DOI: | 10.1093/ijpp/riad072 |
PMID: | 37936510 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2042-7174 |
---|---|
DOI: | 10.1093/ijpp/riad072 |